• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by BGM Group Ltd.

    5/27/25 4:30:03 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BGM alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)


    BGM Group Ltd.

    (Name of Issuer)


    Class A Ordinary Share, par value $0.00833335 per share

    (Title of Class of Securities)


    G7307E123

    (CUSIP Number)


    AIFU INC.
    c/o Mingxiu Luan, 27/F, Pearl River Towe, No. 15 West Zhujiang Road
    Guangzhou, F4, 510623
    86-020-83886888

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    05/23/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    G7307E123


    1 Name of reporting person

    AIFU Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    16,529,330.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    16,529,330.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    16,529,330.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    8.99 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    (1) Note to Row 7, 9, 11: Represents 16,529,330 Class A ordinary shares, par value $0.001 per Class A ordinary share, of BGM Group Ltd. (the "Issuer") held by CISG Holdings Ltd, which is wholly owned by AIFU Inc. (2) Note to Row 13: The percentage calculation is based on 183,959,931 ordinary shares, including 163,959,931 Class A ordinary shares and 20,000,000 Class B ordinary shares, of the Issuer outstanding according to internal records of the Issuer.


    SCHEDULE 13D

    CUSIP No.
    G7307E123


    1 Name of reporting person

    CISG Holdings Ltd.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    VIRGIN ISLANDS, BRITISH
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    16,529,330.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    16,529,330.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    16,529,330.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    8.99 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    (3) Note to Row 7, 9, 11: Represents 16,529,330 Class A ordinary shares, par value $0.001 per Class A ordinary share, of BGM Group Ltd. (the "Issuer") held by CISG Holdings Ltd, which is wholly owned by AIFU Inc. (4) Note to Row 13: The percentage calculation is based on 183,959,931 ordinary shares, including 163,959,931 Class A ordinary shares and 20,000,000 Class B ordinary shares, of the Issuer outstanding according to internal records of the Issuer.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A Ordinary Share, par value $0.00833335 per share
    (b)Name of Issuer:

    BGM Group Ltd.
    (c)Address of Issuer's Principal Executive Offices:

    No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, CHINA , 610200.
    Item 1 Comment:
    This Amendment No. 1 ("Amendment No. 1") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission on January 6, 2025 (the "Original Schedule 13D").
    Item 2.Identity and Background
    (a)
    The information previously provided in response to Item 2 is hereby amended and restated by replacing the text thereof in its entirety with the following: This Schedule 13D is being filed jointly by AIFU Inc. ("AIFU") and CISG Holdings Ltd. ("CISG") (each, a "Reporting Person" and together, the "Reporting Persons") pursuant to Rule 13d-1(k) promulgated by the SEC under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). CISG is 100% held by AIFU.
    (b)
    The principal business and office address of AIFU is 27F, Pearl River Tower, No. 15 West Zhujiang Road, Zhujiang New Town, Tianhe, Guangzhou, Guangdong Province, People's Republic of China. The registered address of CISG is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands.
    (c)
    AIFU is a holding company whose Class A ordinary shares are listed on the Nasdaq Global Select Market. Through its various subsidiaries and affiliated entities, AIFU operates as a leading AI-driven independent financial service provider in China. CISG is a holding company without any substantive operations.
    (d)
    During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
    (e)
    During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such law
    (f)
    AIFU is an exempt company with limited liability incorporated under the laws of Cayman Islands. CISG is an exempt company with limited liability incorporated under the laws of British Virgin Island.
    Item 3.Source and Amount of Funds or Other Consideration
     
    Item 3 of the Statement is hereby amended and and restated by incorporating by reference into Item 4, as applicable.
    Item 4.Purpose of Transaction
     
    Item 4 of the Statement is hereby amended and restated by replacing the text thereof in its entirety with the following: On March 12, 2025, CISG entered into share transfer agreements ("Agreements") with four third party investment firms (the "Purchasers"). Pursuant to the Agreements, CISG will transfer a total of 53,466,331 Class A ordinary shares of the Issuer to such Purchasers, with each of the Purchasers acquiring 20,000,000, 20,000,000, 6,733,166 and 6,733,165 Class A ordinary shares of BGM respectively, in exchange for an aggregate consideration of US$106,932,662 (the "Share Transfer") . The Share Transfer has been completed on May 23, 2025 ("Closing Date"), and the consideration will be paid in two installments within two years from the Closing Date. Following the closing of the Share Transfer, AIFU, through CISG, will own approximately 8.99% of the issued and outstanding ordinary shares of the Issuer and 0.76% of its voting power. The purpose of the Share Transfer is to enhance the Company's capital efficiency and financial flexibility, The Reporting Persons acquired beneficial ownership of the Ordinary Shares of the Issuer as described in this Schedule 13D/A for investment purposes. Consistent with the Reporting Persons' investment purposes, the Reporting Persons may engage in communications with, without limitation, one or more shareholders of the Issuer, management of the Issuer or one or more members of the board of directors of the Issuer, and may make suggestions concerning the Issuer's operations, prospects, business and financial strategies, strategic direction and transactions, assets and liabilities, business and financing alternatives and such other matters as the Reporting Persons may deem relevant to their investment in the Ordinary Shares. Although the Reporting Persons have no present plans or proposals to acquire or disposal of additional Ordinary Shares of the Issuer, the Reporting Persons may, from time to time, review their investment position in the Issuer and may make additional purchases of Ordinary Shares (or other securities convertible or exercisable into Ordinary Shares) in the open market or in privately negotiated transactions, or hold or dispose of all or part of their investments in the Ordinary Shares, depending upon the Reporting Persons' evaluation of the Issuer's business, prospects, financial condition and strategic direction, the market for the Ordinary Shares, other opportunities available to the Reporting Persons, general economic conditions, stock market conditions and other factors.
    Item 5.Interest in Securities of the Issuer
    (a)
    The information previously provided in response to Item 5 is hereby amended and restated by replacing the text thereof in its entirety with the following: (1) The aggregate number of ordinary shares beneficially owned by the Reporting Persons represents 16,529,330 Class A ordinary shares of the Issuer directly held by CISG which is 100% held by AIFU. Pursuant to Section 13(d) of the Exchange Act and the rules promulgated thereunder, AIFU may be deemed to beneficially own all of the Class A ordinary shares of the Issuer held by CISG. (2) The Reporting Persons' aggregate percentage of beneficial ownership is 8.99%, representing 0.76% of the voting power of the Issuer. Percentage of beneficial ownership of each Reporting Person is based on 183,959,931 ordinary shares outstanding as of April 30, 2025, including 163,959,931 Class A ordinary shares and 20,000,000 Class B ordinary shares, based on the internal records of the Issuer. Each Class A ordinary share is entitled to one (1) vote while each Class B ordinary share is entitled to one hundred (100) votes on any and all matters submitted for a vote.
    (b)
    Each of the Reporting Persons has sole voting and dispositive power over the Ordinary Shares of the Issuer reported in this Schedule 13D/A.
    (c)
    During the 60 days preceding the filing of this Schedule 13D/A, none of the Reporting Persons and, to their knowledge, none of the director and officer of the Reporting Persons has effected any transactions in the Ordinary Shares of the Issuer except as reported herein.
    (d)
    To the best knowledge of the Reporting Persons, except for the agreement described in this Schedule 13D/A, no one other than the Reporting Persons, or the holders of interests in the Reporting Persons, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares of the Issuer that they beneficially own.
    (e)
    Not applicable.
    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
     
    Except as described above or elsewhere in this Statement or incorporated by reference in this Statement, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Person and between the Reporting Persons and any person with respect to any securities of the Company, including, but not limited to, transfer or voting of any securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.
    Item 7.Material to be Filed as Exhibits.
     
    Exhibit 1: Joint Filing Agreement dated April 30, 2025 by and between the Reporting Persons Exhibit 2: List of directors and executive officers of (i) AIFU Inc. and (ii) CISG Holdings Inc. (filed herewith) Exhibit 10.1: Form of Share Purchase and Sale Agreement made among CISG Holdings Ltd., BGM Group Ltd. and each of Champ Prestige Limited, Qingyue Limited, Shimmering Holdings Ltd. and Ever Full Co., Ltd. (Incorporated by reference to Exhibit 4.12 of the amendment No. 1)

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    AIFU Inc.
     
    Signature:/s/ Mingxiu Luan
    Name/Title:Mingxiu Luan/Director
    Date:05/27/2025
     
    CISG Holdings Ltd.
     
    Signature:/s/ Hui Wang
    Name/Title:Hui Wang/Director
    Date:05/27/2025
    Get the next $BGM alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BGM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BGM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025

      CHENGDU, China, July 23, 2025 /PRNewswire/ -- BGM Group (the "Company" or "BGM") (NASDAQ:BGM) today announced that it will release its unaudited financial results for the first half 2025 before the U.S. financial markets open on July 24, 2025 Eastern Daylight Time. About BGM  BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. In terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services

      7/23/25 6:36:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

      CHENGDU, China, May 28, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM)  (NASDAQ:BGM) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 million. The consideration will be paid through the issuance of 37,123,142 newly issued Class A ordinary shares of BGM at a price of US$3.0 per share. The transactions are expected to close by the end of June 2025, subject to

      5/28/25 4:30:00 PM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem

      CHENGDU, China, May 2, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) (the "Company" or "BGM") , a leading AI technology company, today announced it has entered into a definitive agreement (the "Agreement") to acquire HM Management Company Limited ("HM Management"), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million). Under the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. ("Shuda Technology") and New Media Star Technology (Shenzhen) Co., Ltd ( "New Media Star

      5/2/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BGM
    SEC Filings

    See more
    • SEC Form 6-K filed by BGM Group Ltd.

      6-K - BGM Group Ltd. (0001779578) (Filer)

      7/24/25 7:31:02 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by BGM Group Ltd.

      6-K - BGM Group Ltd. (0001779578) (Filer)

      6/26/25 6:04:07 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form S-8 filed by BGM Group Ltd.

      S-8 - BGM Group Ltd. (0001779578) (Filer)

      6/3/25 4:31:34 PM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BGM
    Financials

    Live finance-specific insights

    See more
    • From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

      CHENGDU, China, May 28, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM)  (NASDAQ:BGM) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 million. The consideration will be paid through the issuance of 37,123,142 newly issued Class A ordinary shares of BGM at a price of US$3.0 per share. The transactions are expected to close by the end of June 2025, subject to

      5/28/25 4:30:00 PM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

      CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of RMB550 million. The transaction is expected to be completed in the second quarter of 2025. Wonder Dragon possesses over 3,000 metric tons of premium Qingzhuan dark tea inventory, comprising 1,670 metric tons of raw materials and 1,350 metric tons of finished products. These premium tea products, known f

      4/21/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform

      CHENGDU, China, March 19, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM) (NASDAQ:BGM) today announced that it has signed a definitive agreement with the existing shareholders of YX Management Company Ltd. ("YX"), a smart mobility technology company. Under the agreement, BGM will acquire 100% of the equity interests of YX by issuing 47.5 million class A ordinary shares to its existing shareholders, valuing YX at US$95.0 million. This acquisition is based on the exceptional expertise and experience of the YX team in scalable operations, digital infrastructure development, and technology commercialization. The integration of this team will accelerate the AI-driven strategic upgrade

      3/19/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BGM
    Leadership Updates

    Live Leadership Updates

    See more
    • BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution

      CHENGDU, China, Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ:BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase of technological transformation and sustainable growth. Mr. Zhanchang Xin has tendered his resignation and will step down from his role as Chairman of the Company, effective March 1, 2025. He will be succeeded by Mr. Chen Xin, the current Chief Executive Officer of the Company, who will assume the position of Chairman. As the founder of the Company, Mr. Zhanchang Xin has, over the past six decades, has played a pivotal role in leading the Company through numerous challenges and milestones, including

      2/28/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry

      CHENGDU, China, Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem. This move signifies BGM Group's strategic entry into the field of artificial intelligence, aiming to accelerate the transformation of the insurance industry into the smart era through AI technology. The Duxiaobao Management Committee consists of industry leaders such as Xin Chen, Li Yuqing, Ge Peng, Zhao Qi, Ren Yong, Li Jun, Zhou Xin, and Wang Hui. The committee has appointed Li Yuqing as the CEO of Duxiaobao, with Li Jun, Ren Yong, Zhou Xin, and Tan

      2/19/25 7:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by BGM Group Ltd.

      SC 13D - BGM Group Ltd. (0001779578) (Subject)

      12/3/24 6:03:06 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by BGM Group Ltd.

      SC 13D/A - BGM Group Ltd. (0001779578) (Subject)

      11/29/24 9:00:27 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D filed by Qilian International Holding Group Ltd.

      SC 13D - Qilian International Holding Group Ltd (0001779578) (Subject)

      10/16/24 4:19:46 PM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care